Koneksa Health develops digital biomarkers for use in pharamceutical and biopharmaceutical clinical trials. Contact us today to learn more.
Location: United States, New York
Employees: 51-200
Total raised: $61M
Founded date: 2015
Investors 3
| Date | Name | Website |
| - | dRx Capita... | drxcapital... |
| 28.09.2020 | McKesson V... | ventures.m... |
| - | dRx Capita... | live-drxca... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 08.02.2022 | Series C | $45M | - |
| 29.09.2020 | Series B | $16M | - |
Mentions in press and media 18
| Date | Title | Description | Source |
| 28.06.2023 | Koneksa Appoints Dave Hurry as Chief Data Officer and Dr. La... | Koneksa, the evidence-based digital biomarkers company, announced the appointment of Dave Hurry as C... | aithority.... |
| 10.03.2023 | Chris Benko, co-founder and CEO of Koneksa Health, on VatorN... | Koneksa Health is a company that is developing, testing, and validating digital biomarkers Vator · ... | vator.tv/n... |
| 14.02.2022 | Digital health news, funding roundup in the prior week; Febr... | Amazon expanded its on-demand health solution; Medable partnered with CVS; COVID deaths passed 900k ... | vator.tv/n... |
| 08.02.2022 | Koneksa secures $45M for digital biomarker platform | Koneksa has raised a $45 million Series C led by AyurMaya, an affiliate of Matrix Capital Management... | pitchbook.... |
| 08.02.2022 | Koneksa Raises $45M in Series C Funding | Koneksa, a New York-based company focused on designing and validating digital biomarkers, raised $45... | finsmes.co... |
| 07.02.2022 | Koneksa Raises $45M Series C | NEW YORK, NY, Koneksa, a leader in designing and validating digital biomarkers, announced the comp... | vcnewsdail... |
| 07.02.2022 | Koneksa Raises $45M Series C Financing to Accelerate Expansi... | Koneksa, the leader in designing and validating digital biomarkers to accelerate drug development, a... | marketscre... |
| 07.02.2022 | Digital biomarker startup Koneksa scores $45M in Series C fu... | Photo: Kwanchai Lerttanapunyaporn/Getty Images Digital biomarker startup Koneksa announced a $45 mi... | mobihealth... |
| 07.02.2022 | Frontier and Spirit Airlines to take on the pandemic-induced... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 07.02.2022 | Takeda joins Novartis and Merck in $45M funding for Koneksa ... | Takeda Ventures has joined Novartis and Merck in backing Koneksa Health, which bills itself as a dig... | fiercebiot... |
Show more